RAIN — Rain Oncology Balance Sheet
0.000.00%
HealthcareMicro Cap
- $44.03m
- -$33.29m
Annual balance sheet for Rain Oncology, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|
Period Length: | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
Standards: | USG | USG | USG | USG |
Status: | Final | Final | Final | Final |
Cash and Equivalents | ||||
Short Term Investments | ||||
Cash and Short Term Investments | 5.79 | 58.9 | 140 | 130 |
Prepaid Expenses | ||||
Total Other Current Assets | ||||
Total Current Assets | 6.27 | 59.5 | 146 | 134 |
Gross Property, Plant And Equipment | ||||
Accumulated Depreciation | ||||
Net Property, Plant And Equipment | 0.692 | 0.546 | 0.551 | 0.351 |
Long Term Notes Receivable | ||||
Other Long Term Assets | ||||
Total Assets | 7.39 | 61.1 | 147 | 135 |
Accounts Payable | ||||
Accrued Expenses | ||||
Notes Payable / Short Term Debt | ||||
Total Other Current Liabilities | ||||
Total Current Liabilities | 1.22 | 3.42 | 16.3 | 22 |
Long Term Debt | ||||
Total Long Term Debt | ||||
Total Debt | ||||
Total Other Liabilities | ||||
Total Liabilities | 4.5 | 3.8 | 16.6 | 22.1 |
Redeemable Preferred Stock | ||||
Non Redeemable Preferred Stock | ||||
Common Stock | ||||
Additional Paid In Capital | ||||
Retained Earnings (Accumulated Deficit) | ||||
Other Equity | ||||
Total Equity | 2.9 | 57.3 | 131 | 113 |
Total Liabilities & Shareholders' Equity | 7.39 | 61.1 | 147 | 135 |
Total Common Shares Outstanding |